Description |
1 online resource (xxx, 489 pages) : illustrations |
Series |
Advances in behavioral biology ; 57 |
|
Advances in behavioral biology ; 57.
|
Contents |
Clinical Features and Treatment of Dementia Associated With Parkinson's Disease -- Neurogenetics in Parkinson's Disease -- Impaired DNA Repair Systems: Generation of Mitochondrial Dysfunction and Increased Sensitivity to Excitotoxicity -- Current Problems and Strategies in Motor Rehabilitation for Parkinson's Disease -- Critical Acute Akinesia in Parkinson's Disease Patients Concomitant with Additional Precipitating Factors Other Than Treatment Withdrawal: A Possible Lethal Complication -- Biomarkers for Early Detection of Parkinson's Disease: An Essential Challenge -- Neurotransmitter and Neurotrophic Factor-Secreting Cell Line Grafting for the Treatment of Parkinson's Disease -- Novel Therapeutic Target in PD: Experimental Models -- LRRK2 (Leucine-Rich Repeat Kinase 2) Gene on PARK8 Locus in Families with Parkinsonism -- Microglia Activation and Gene Expression of Cytokines in Parkinson's Disease -- Dissecting the Biochemical Pathways Mediated by Genes Implicated in Parkinson's Disease: Induction of DJ-1 Expression in A30P?-Synuclein Mice -- Neuroinflammation in Early Stages of Alzheimer's Disease and Parkinson's Disease -- Alzheimer's Disease, Parkinson's Disease, and Frontotemporal Dementias: Different Manifestations of Protein Misfolding -- Role of Oxidative Insult and Neuronal Survival in Alzheimer's and Parkinson's Diseases -- Redox Proteomics Identification of Oxidatively Modified Proteins in Alzheimer's Disease Brain and in Brain from a Rodent Model of Familial Parkinson's Disease: Insights into Potential Mechanisms of Neurodegeneration -- Biomarkers for Alzheimer's Disease and Parkinson's Disease -- Bioluminescent Imaging of Excitotoxic and Endotoxic Brain Injury in Living Mice -- Alzheimer's Disease Neuroimaging Initiative -- Two Hits and You're Out? A Novel Mechanistic Hypothesis of Alzheimer Disease -- Vascular Risk Factors and Risk for Alzheimer's Disease and Mild Cognitive Impairment: Population-Based Studies -- Cholesterol Transport and Production in Alzheimer's Disease -- Cholesterol and A? Production: Methods for Analysis of Altered Cholesterol De Novo Synthesis -- Glycosaminoglycans and Analogs in Neurodegenerative Disorders -- Prospective Role of Glycosaminoglycans in Apoptosis Associated with Neurodegenerative Disorders -- Stem Cell Therapy in Alzheimer's Disease -- Oral A? Vaccine Using a Recombinant Adeno-Associated Virus Vector in an Alzheimer's Disease Mouse Model -- In Vivo Targeting of Amyloid Plaques Via Intranasal Administration of Phage Anti-?-Amyloid Antibodies -- Decreased ProBDNF: The Cause of Alzheimer's-Associated Neurodegeneration and Cognitive Decline? -- Shift in the Balance of TRKA and ProNGF in Prodromal Alzheimer 's Disease -- Neuroprotective Effects of Trophic Factors and Natural Products: Involvement of Multiple Intracellular Kinases -- Intraneuronal A? and Alzheimer's Disease -- Physiological Processing of the Cellular Prion Protein and?APP: Enzymes and Regulation -- Expression of Wnt Receptors, Frizzled, in Rat Neuronal Cells -- Cell Models of Tauopathy -- Co-expression of FTDP-17 Human Tau and GSK-3 (or APPSW) in Transgenic Mice: Induction of Tau Polymerization and Neurodegeneration -- Enhanced Activation of NF-?B Signaling by Apolipoprotein E4 -- Pleiotropic Effects of Apolipoprotein E in Dementia: Influence on Functional Genomics and Pharmacogenetics -- Up-regulation of the?-Secretase Pathway -- Frequency and Relation of Argyrophilic Grain Disease and Thorn-Shaped Astrocytes in Alzheimer's Disease -- Cellular Membranes as Targets in Amyloid Oligomer Disease Pathogenesis -- Ganglioside-Dependent Generation of a Seed for Alzheimer's Disease Amyloid -- Evidence That Amyloid Pathology Progresses in a Neurotransmitter-Specific Manner -- Rationale for Glutamatergic and Cholinergic Approaches for the Treatment of Alzheimer's Disease -- Cortical Cholinergic Lesion Causes A? Deposition: Cholinergic-Amyloid Fusion Hypothesis -- Expression of Acetylcholinesterase in Alzheimer's Disease Brain: Role in Neuritic Dystrophy and Synaptic Scaling -- Role of b-Amyloid in the Pathophysiology of Alzheimer's Disease and Cholinesterase Inhibition: Facing the Biological Complexity to Treat the Disease -- Dissociation Between the Potent?-Amyloid Protein Pathway Inhibition and Cholinergic Actions of the Alzheimer Drug Candidates Phenserine and Cymserine -- Allosteric Potentiators of Neuronal Nicotinic Cholinergic Receptors: Potential Treatments for Neurodegenerative Disorders |
Summary |
Covers topics such as immunology, neuroscience, pharmacology, genetics, molecular biology, biochemistry and the history, epidemiology, clinical phenomenology, diagnosis, imaging, treatment, and other perspectives of Alzheimer's and Parkinson's Diseases |
Bibliography |
Includes bibliographical references and index |
Notes |
Print version record |
Subject |
Alzheimer's disease -- Congresses
|
|
Parkinson's disease -- Congresses
|
|
Alzheimer's disease.
|
|
Alzheimer Disease
|
|
Parkinson Disease
|
|
HEALTH & FITNESS -- Diseases -- Alzheimer's & Dementia.
|
|
MEDICAL -- Neurology.
|
|
Parkinson Disease.
|
|
Alzheimer's disease.
|
|
Parkinson's disease.
|
|
Alzheimer Disease.
|
|
Biomédecine.
|
|
Sciences de la vie.
|
|
Alzheimer's disease.
|
|
Parkinson's disease.
|
Genre/Form |
Conference papers and proceedings.
|
|
Conference papers and proceedings.
|
|
Actes de congrès.
|
Form |
Electronic book
|
Author |
Fisher, Abraham.
|
LC no. |
2007930197 |
ISBN |
9780387720760 |
|
0387720766 |
|
038772074X |
|
9780387720746 |
|